PlainRecalls
FDA Drug Critical Class I Terminated

365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONAL

Reported: February 23, 2022 Initiated: August 2, 2021 #D-0631-2022

Product Description

365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONAL

Reason for Recall

Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.

Details

Recalling Firm
Je Dois Lavoir LLC
Units Affected
783 bottles
Distribution
Sold online via website nationwide in the USA and Canada.
Location
Visalia, CA

Frequently Asked Questions

What product was recalled?
365 SKINNY High Intensity Capsules, 600 mg, 30-count bottle, BODY BALANCE INTERNACIONAL. Recalled by Je Dois Lavoir LLC. Units affected: 783 bottles.
Why was this product recalled?
Marketed Without an Approved NDA/ANDA: FDA analysis found the product to be tainted with undeclared sibutramine, a previously approved drug that was withdrawn from the US market due to safety concerns.
Which agency issued this recall?
This recall was issued by the FDA Drug on February 23, 2022. Severity: Critical. Recall number: D-0631-2022.